HEMODYNAMIC-CHANGES INDUCED BY EPO TREATMENT AFTER ONE YEAR

被引:0
作者
FERNANDEZ, A
HORTAL, L
VEGA, N
JIMENEZ, F
LARAUDIOGOITIA, E
PERDOMO, M
MACIA, M
PLAZA, C
PALOP, L
机构
来源
NEFROLOGIA | 1992年 / 12卷
关键词
HYPERTENSION; ERYTHROPOIETIN; HEMODYNAMIC CHANGES;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We have studied 39 patients with Doppler-M mode echocardiography, before starting treatment with erythropoietin, after reaching the target hemoglobin, and after one year of treatment. We evaluated the following echocardiographic parameters: Lek ventricular diameters, lef ventricular weight, fractional shortening and ejection fraction as well as cardiac output index and peripheral vascular resistance index normalized to valvular area. We analized the incidence of hypertension and the relation between hemoglobine levels and ecocardiographics parameters. 35,8 % of the patients developed arterial hypertension during the initial phases of treatment. Neither the basal Hb or target Hb were different in this group. Wen target hemoglobine was reached, cardiac output was less and peripheral resistances were higher in patients with Hb > 10,5 g/dl than in those with lower figures. The differences dissappeared after one year of treatment. During this period the ventricular function got better only in the patients with higher levels of hemoglobine. This behaviour suggest that it is convenient as effective correction of the anemia to improve the ventricular function on the long term. Nevertheless, we think that during the initial phases of treatment the correction must be done slowly to avoid as much as possible the initial hemodinamic effects.
引用
收藏
页码:94 / 98
页数:5
相关论文
共 50 条
[31]   Stress-induced hemodynamic and hemostatic changes in patients with systemic hypertension: Effect of verapamil [J].
Gebara, OCE ;
Jimenez, AH ;
McKenna, C ;
Mittleman, MA ;
Xu, P ;
Lipinska, I ;
Muller, JE ;
Tofler, GH .
CLINICAL CARDIOLOGY, 1996, 19 (03) :205-211
[32]   EPO treatment does not alter acute serum profiles of GFAP and S100B after TBI: A brief report on the Australian EPO-TBI clinical trial [J].
Hellewell, Sarah C. ;
Conquest, Alison ;
Little, Lorraine ;
Valiance, Shirley ;
Board, Jasmin ;
Bellomo, Rinaldo ;
Cooper, David J. ;
Morganti-Kossmann, Maria Cristina D. I. G. .
JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 76 :5-8
[33]   Clinical value of hemodynamic changes in diagnosis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt [J].
Li, Wanyan ;
Duan, Yayang ;
Liu, Zhike ;
Lu, Xiaofeng ;
She, Jingwen ;
Qing, Jing ;
Zhang, Chaoxue .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (06) :713-718
[34]   Investigation the Effects of Phenylephrine on Oxytocin-Induced Hemodynamic Changes in Women Undergoing Cesarean Section [J].
Nouri, Lida ;
Bakhtar, Niloofar .
JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (47B) :279-285
[35]   Quantitative analysis of hemodynamic changes induced by the discrepancy between the sizes of the flow diverter and parent artery [J].
Kim, Sunghan ;
Yang, Hyeondong ;
Oh, Je Hoon ;
Kim, Yong Bae .
SCIENTIFIC REPORTS, 2024, 14 (01)
[36]   Losartan exerts no protective effects against acute pulmonary embolism-induced hemodynamic changes [J].
Dias-Junior, Carlos A. ;
Neto-Neves, Evandro M. ;
Montenegro, Marcelo F. ;
Tanus-Santos, Jose E. .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 (02) :211-217
[37]   One year of antihypertensive treatment in patients with LVH:: The LIFE study. [J].
Kjeldsen, SE ;
Dahlöf, B ;
Devereux, RB ;
Julius, S ;
Beevers, G ;
Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristianson, K ;
Pedersen, OL ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) :142A-142A
[38]   Microalbuminuria in hypertensive patients: Evaluation of one-year treatment with irbesartan [J].
de Alvaro, F ;
Velasco, O ;
Honorato, J ;
Calvo, C ;
Parrondo, I .
KIDNEY INTERNATIONAL, 2005, 67 :S29-S34
[39]   Change in diastolic left ventricular filling after one year of antihypertensive treatment -: The losartan intervention for endpoint reduction in hypertension (LIFE) study [J].
Wachtell, K ;
Bella, JN ;
Rokkedal, J ;
Palmieri, V ;
Papademetriou, V ;
Dahlöf, B ;
Aalto, T ;
Gerdts, E ;
Devereux, RB .
CIRCULATION, 2002, 105 (09) :1071-1076
[40]   Cardiovascular risk factors in pediatric patients after one year of renal transplant [J].
Araujo Alves Carvalho, Lindia Kalliana da Costa ;
Lima, Shirley Mendonca ;
Carneiro, Vanessa Ayres ;
de Leite, Renata Fabiana ;
Luiz Pereira, Aline Maria ;
Medina Pestana, Jose Osmar .
ACTA PAULISTA DE ENFERMAGEM, 2010, 23 (01) :114-118